Premium
Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: Guidance from the British Committee for Standards in Haematology
Author(s) -
Baglin Trevor,
Keeling David,
Kitchen Steve
Publication year - 2012
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.12052
Subject(s) - dabigatran , rivaroxaban , medicine , direct thrombin inhibitor , pharmacology , thrombin time , discovery and development of direct thrombin inhibitors , pharmacokinetics , anticoagulant , bioequivalence , prodrug , pharmacodynamics , prothrombin complex concentrate , coagulation testing , prothrombin time , bioavailability , anesthesia , coagulation , thrombin , warfarin , atrial fibrillation , partial thromboplastin time , platelet